Literature DB >> 7736533

Recombinant proteins L and LG. Two new tools for purification of murine antibody fragments.

R Vola1, A Lombardi, L Tarditi, M Zaccolo, D Neri, L Björck, M Mariani.   

Abstract

Several bacterial cell wall proteins, like proteins A and G, with valuable affinity for immunoglobulins have been discovered and are currently employed in immunological techniques. In 1988, protein L, a bacterial cell wall protein with Ig-binding capacity, was isolated from the anaerobic bacterial species Peptostreptococcus magnus. Binding data with immunoglobulin fragments suggested that protein L could selectively bind the variable region of human kappa light chains. More recently a recombinant LG fusion protein was expressed in E. coli containing four repeated Ig-binding domains of protein L (fragment B1-4) and two IgG Fc-binding protein G domains (fragment CDC). Recombinant L and LG proteins were tested in the purification of murine monoclonal IgG and their fragments. After affinity-constant evaluation in different buffer systems, high-pressure affinity-chromatography columns were prepared by coupling the proteins to Affi-prep 10 resin and tested with eight different murine monoclonal antibodies and their fragments of various isotypes. Affinity-chromatography experiments confirming radioimmunoassay results showed 75% fragment-binding capacity of protein L and 100% of protein LG. These results evidenced protein LG as the most powerful Ig-binding tool so far described. Therefore, application of these proteins may be suggested in the purification of murine immunoglobulins and their fragments, including the engineered ones.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7736533     DOI: 10.1007/bf02789212

Source DB:  PubMed          Journal:  Cell Biophys        ISSN: 0163-4992


  19 in total

1.  Antigen specificity and cross-reactivity of monoclonal anti-lysozyme antibodies.

Authors:  M Harper; F Lema; G Boulot; R J Poljak
Journal:  Mol Immunol       Date:  1987-02       Impact factor: 4.407

2.  "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin.

Authors:  A Forsgren; J Sjöquist
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

3.  An interactive computer program for the determination of the binding constants of monoclonal antibodies by non-linear regression analysis of radioimmunoassay data.

Authors:  G Antoni; M Mariani
Journal:  J Immunol Methods       Date:  1985-10-24       Impact factor: 2.303

4.  VL-VH expression by monoclonal antibodies recognizing avian lysozyme.

Authors:  S J Smith-Gill; C R Mainhart; T B Lavoie; S Rudikoff; M Potter
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

5.  A new enzymatic method to obtain high-yield F(ab)2 suitable for clinical use from mouse IgGl.

Authors:  M Mariani; M Camagna; L Tarditi; E Seccamani
Journal:  Mol Immunol       Date:  1991 Jan-Feb       Impact factor: 4.407

6.  Purification and some properties of streptococcal protein G, a novel IgG-binding reagent.

Authors:  L Björck; G Kronvall
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

7.  CAR-3, a monoclonal antibody-defined antigen expressed on human carcinomas.

Authors:  M Prat; I Morra; G Bussolati; P M Comoglio
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

8.  Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.

Authors:  G Buraggi; L Callegaro; A Turrin; L Gennari; E Bombardieri; G Mariani; G Deleide; M Dovis; M Gasparini; R Doci
Journal:  Cancer Detect Prev       Date:  1987

9.  Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.

Authors:  B S Wilson; K Imai; P G Natali; S Ferrone
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

10.  Structure of the IgG-binding regions of streptococcal protein G.

Authors:  B Guss; M Eliasson; A Olsson; M Uhlén; A K Frej; H Jörnvall; J I Flock; M Lindberg
Journal:  EMBO J       Date:  1986-07       Impact factor: 11.598

View more
  1 in total

Review 1.  Engineering recombinant antibodies for immunotherapy.

Authors:  D Neri; H Petrul; G Roncucci
Journal:  Cell Biophys       Date:  1995-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.